Novamind Inc (OP: NVMDF )

N/A UNCHANGED
Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novamind Inc

< Previous 1 2 Next >
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness  Corp., has entered into a joint venture agreement  with  Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience... 
Via Benzinga
EXCLUSIVE: Bienstar Wellness Starts Treating Patients With Psychedelic Therapy In Brazil, Acquires BRC Saude Mental
Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine... 
Via Benzinga
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. 
Via Benzinga
New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval
Numinus Wellness Inc. 
Via Benzinga
Numinus to Acquire Novamind For $20.74M In Stock
Via Benzinga
Novamind Expands To Arizona With Purchase Of New Ketamine Clinic
Novamind Inc. (Canadian: NM) (OTCQB:NVMDF... 
Via Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. 
Via Benzinga
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics. 
Via Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders
June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF). 
Via Benzinga
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions. 
Via Benzinga
Novamind To Offer Virtual Mental Health Therapy Sessions
Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit 
Via Benzinga
Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action. 
Via Benzinga
Core One Labs Begins Trading On OTCQB
Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB: CLABF) started trading on the OTCQB Venture ... 
Via Benzinga
EXCLUSIVE: Bienstar Wellness Enters Brazilian Psychedelic Market, Will Acquire Ibogaine Co.
Bienstar Wellness Corp., an integrative mental health company specializing in psychedelic medicine with core operations in Latin America, has entered into a binding letter of intent to acquire 100% of... 
Via Benzinga
Novamind To Offer Psychedelic-Assisted Group Therapy
Novamind Inc. (OTCQB: NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name Groups ... 
Via Benzinga
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
The psychedelics space was shaken up on the news thatMindCure Health (OTC: MCURF) was shutting down operations. 
Via Benzinga
Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment
Novamind Inc. (OTCQB: NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ: MNMD)(NEO:MMED) to host ... 
Via Benzinga
Novamind Begins Clinical Trial Of Psilocybin For Depression
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ... 
Via Benzinga
Novamind Stock Slightly Up On Grants Restricted Share Units
Novamind Inc. (OTCQB: NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an ... 
Via Benzinga
Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder
Novamind Inc. (OTCQB: NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major ... 
Via Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ... 
Via Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ... 
Via Benzinga
Novamind Posts Record High Revenue Of CA$2.45M, Up 32% QoQ
Psychedelics-focused mental health company Novamind Inc. (CSE:NM 
Via Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... 
Via Benzinga
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. 
Via Benzinga
Cancer Patients' Case To Use Psilocybin Under Right To Try Law Dismissed By Fed Appeals Court
As the psychedelics space gains traction on many levels, a number of studies are being conducted to examine whether psychedelic medications can or should be used to treat depression in cancer... 
Via Benzinga
Novamind Stock Dives On $3.95M Private Placement With Institutional Investor
Novamind Inc. (CSE:NM) (OTCQB: 
Via Benzinga
The Year In Review For Psychedelic Drug Stocks: 2021
2021 was two different 
Via Talk Markets
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.